IL-6 signaling had only minor effects in the absence of TCR activation; increased STAT3 (Tyr705) signaling in response to trans-signaling (i.e., hyper-IL-6) for patients with previous GVHD was the only exception, showing a highly significant difference in resting cells. This evidence concerns the gene STAT3 and graft versus host disease.